English (international)
Eesti
Български
Deutsch
Français
Español (Latinoamérica)
Polski
Magyar
Română
Lonza Group AG
Fermé
536 0.49
Résumé
Variation du prix de l'action
24h
Min
536
Max
539.4
Revenu | 244M |
|---|---|
Ventes | -582M 3.1B |
P/E Moyenne du Secteur | 26.67 |
BPA | 4.61 |
Marge bénéficiaire | 6.705 |
Capitalisation Boursière | -144M 40B |
|---|---|
Ouverture précédente | 535.51 |
Clôture précédente | 536 |
Sentiment de l'Actualité
By Acuity
50%
50%
Lonza Group AG Graphique
Actualités Associées
Lonza Group AG prévision
Sentiment
By Acuity
Sentiment de l'Actualité
Neutral
Volatilité
Inférieur à la moyenne
Changement du Volume d'Actualités (RCV)
Supérieur à la moyenne
Éléments financiers
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$
À Propos Lonza Group AG
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.